row 1 question: Which three types of cells were used to generate sphere skin organoids, and what was their mixing ratio? k24_c1200: The three types of cells used to generate sphere skin organoids were human-derived keratinocytes, fibroblasts, and endothelial cells. They were mixed in a 2:1:1 ratio [Source: 3-D bioprinted human-derived skin organoids accelerate full-thickness skin defec.pdf, Page: 4]. row 2 question: Why did the researchers innovate a "dual-photo source cross-linking" technique for their 3D bioprinting process instead of using a traditional single-source approach? k24_c1200: The researchers innovated a "dual-photo source cross-linking" technique to reduce the illumination time required for the bioink to be completely formed, thereby minimizing the adverse effects of light radiation on the sphere skin organoids. This approach contrasts with the traditional single-photo source or common photo-curing bioprinting technology, which may expose the bioink to longer periods of light radiation, potentially causing more damage to the cells [Source: 3-D bioprinted human-derived skin organoids accelerate full-thickness skin defec.pdf, Page: 12]. row 3 question: What are the specific components and their concentrations in the optimized bioink formulation used for the DLP-based printing of the hepatic tissue constructs? k24_c1200: The optimized bioink formulation for the DLP-based printing of hepatic tissue constructs involved a series of PEG polymers with varying numbers of arms and molecular weights combined with GelMA. Among these formulations, the 10 kDa 4-arm PEG-A demonstrated the highest compression modulus and superior printing accuracy. However, specific concentrations of these components in the optimized formulation are not detailed in the provided context [Source: 3D bioprinted thick hepatic constructs with vascular network as a physiologicall.pdf, Page: 4]. row 4 question: Why did the researchers design the hepatic tissue constructs with a "gyroid-shaped architecture" rather than other structures? k24_c1200: The researchers designed the hepatic tissue constructs with a "gyroid-shaped architecture" because this design promotes uniform fluid flow and optimal surface shear stress, which enhances nutrient and oxygen distribution throughout the cell-laden construct. The gyroid structure, characterized by its interconnected channels, supports uniform cell distribution, enhanced viability, and sustained hepatic functionality under dynamic culture conditions. This architecture effectively mimics the oxygen and nutrient delivery systems found in living tissues, making it a promising solution for enhancing cell viability and functionality in vitro [Source: 3D bioprinted thick hepatic constructs with vascular network as a physiologicall.pdf, Page: 10]. Additionally, the gyroid design demonstrated the ability to produce elevated levels of albumin and bilirubin to a statistically significant extent, indicating enhanced functionality of the hepatic tissue constructs [Source: 3D bioprinted thick hepatic constructs with vascular network as a physiologicall.pdf, Page: 6]. row 5 question: What process was used to isolate and purify extracellular vesicles (EVs) from the conditioned medium of Renal Progenitor Cells (RPCs)? k24_c1200: The process used to isolate and purify extracellular vesicles (EVs) from the conditioned medium of Renal Progenitor Cells (RPCs) involved several steps. Initially, the conditioned medium was centrifuged sequentially at 400 × g for 5 minutes and 2000 × g for 10 minutes to remove cells and debris. This was followed by concentration using 100 kDa molecular weight cut-off Amicon centrifugal filters at 4000 × g for 30 minutes. Further purification of EVs was achieved by size-exclusion chromatography (SEC) using 35 mm qEV columns coupled with an Automatic Fraction Collector (AFC, Izon Science), with DPBS used as the elution buffer. EV-enriched fractions were identified by nanoparticle tracking analysis (NTA) and protein quantification, then concentrated using 10 kDa molecular weight cut-off Amicon filters [Source: 3D bioprinting meets nanotherapeutics a vehicle for sustained extracellular vesi.pdf, Page: 3]. row 6 question: How did Renal Progenitor Cell (RPC)-derived extracellular vesicles (EVs) influence HK-2 tubular epithelial cells when subjected to hypoxic conditions? k24_c1200: Renal Progenitor Cell (RPC)-derived extracellular vesicles (EVs) influenced HK-2 tubular epithelial cells under hypoxic conditions by modulating several cellular responses. The EV treatment did not significantly alter the metabolic activity of the cells compared to normoxic controls, indicating that the cells maintained metabolic homeostasis under hypoxic stress or due to the influence of EVs [Source: 3D bioprinting meets nanotherapeutics a vehicle for sustained extracellular vesi.pdf, Page: 7-8]. However, the EV treatment significantly reduced the proportion of Ki67-positive proliferating cells, suggesting a modulation of excessive proliferative responses induced by hypoxia, bringing them closer to normoxic levels [Source: 3D bioprinting meets nanotherapeutics a vehicle for sustained extracellular vesi.pdf, Page: 7]. Additionally, the EV-treated cells exhibited lower levels of reactive oxygen species (ROS) compared to untreated hypoxic controls, indicating a protective effect against oxidative stress [Source: 3D bioprinting meets nanotherapeutics a vehicle for sustained extracellular vesi.pdf, Page: 8]. Furthermore, the expression of SOX9, a key transcription factor in tubular injury response, was significantly reduced in EV-treated cells, suggesting a modulation of injury-response pathways [Source: 3D bioprinting meets nanotherapeutics a vehicle for sustained extracellular vesi.pdf, Page: 8]. However, the EVs had minimal influence on the migration of HK-2 cells under hypoxic conditions [Source: 3D bioprinting meets nanotherapeutics a vehicle for sustained extracellular vesi.pdf, Page: 9]. row 7 question: In the paper "3D bioprinting of engineered exosomes secreted from M2-polarized macrophages through immunomodulatory biomaterial promotes in vivo wound healing and angiogenesis", what were the two types of bioinks formulated, and what were their specific applications? k24_c1200: In the study "3D bioprinting of engineered exosomes secreted from M2-polarized macrophages through immunomodulatory biomaterial promotes in vivo wound healing and angiogenesis," two types of bioinks were formulated: 1. **Bioink-I**: This was a catecholamine-based bioink composed of alginate/gelatin/polydopamine nanospheres (Alg/Gel/PDA NSPs). Its purpose was to facilitate macrophage adhesion, proliferation, and polarization, thereby enhancing exosome secretion from M2 polarized monocyte/macrophages [Source: 3D bioprinting of engineered exosomes secreted from M2-polarized macrophages thr.pdf, Page: 2]. 2. **Bioink-II**: This was a collagen/skin-derived decellularized extracellular matrix (COL@d-ECM-mExo-AGP) bioink. It was developed for 3D skin printing using human dermal fibroblasts (hDFs), keratinocytes (hKCs), stem cells (hMSCs), and endothelial cells (hECs). This bioink exhibited shear-thinning properties and remarkable shape fidelity during bioprinting, aimed at enhancing skin regeneration and wound healing [Source: 3D bioprinting of engineered exosomes secreted from M2-polarized macrophages thr.pdf, Page: 2]. row 8 question: What evidence demonstrates the therapeutic efficacy of the COL@d-ECM/M2-Exo hydrogel in rat subcutaneous wound models after 14 days? k24_c1200: The therapeutic efficacy of the COL@d-ECM/M2-Exo hydrogel in rat subcutaneous wound models after 14 days is demonstrated through several observations: 1. **Wound Healing Performance**: The COL@d-ECM + Exo group showed a significant decrease in wound size compared to the control group after 14 days of incubation, indicating better wound healing performance [Source: 3D bioprinting of engineered exosomes secreted from M2-polarized macrophages thr.pdf, Page: 14]. 2. **Microscopic Analysis**: H & E and Massion’s Trichrome staining revealed that the COL@d-ECM + Exo-treated groups exhibited superior healing ability with thick epidermis, granulation tissue, various glands, and hair follicle growth. The group demonstrated significantly higher rates of skin re-epithelization and thick epidermis formation compared to the control group [Source: 3D bioprinting of engineered exosomes secreted from M2-polarized macrophages thr.pdf, Page: 14]. 3. **Immunomodulatory Effects**: The COL@d-ECM + M2-Exo group displayed reduced expression of pro-inflammatory markers (CD86+ and NOS2+ cells) and a significant increase in anti-inflammatory markers (CD163+ and CD206+ cells), suggesting a positive role in wound healing by accumulating anti-inflammatory cells and their secreted cytokines at or near the wound bed [Source: 3D bioprinting of engineered exosomes secreted from M2-polarized macrophages thr.pdf, Page: 16]. 4. **Reduction in Inflammation**: The COL@d-ECM + Exo scaffold treatment showed a reduction in inflammation score, suggesting that Exo therapy using an ECM mimicking hydrogel had the potential to reduce skin inflammation and thereby accelerate the wound healing process [Source: 3D bioprinting of engineered exosomes secreted from M2-polarized macrophages thr.pdf, Page: 14]. These findings collectively demonstrate the therapeutic efficacy of the COL@d-ECM/M2-Exo hydrogel in enhancing wound healing in rat subcutaneous wound models after 14 days. row 9 question: In the paper "bioprinting of high-performance hydrogel with in-situ birth of stem cell spheroids", what are the two primary components of the cell-concentrated bioink (CCB) described? k24_c1200: The two primary components of the cell-concentrated bioink (CCB) described in the paper are dextran, which acts as a cell decoy to capture the encapsulated cells, and gelatin methacryloyl (GelMA), which serves as the matrix to provide structural integrity [Source: 3D bioprinting of high-performance hydrogel with in-situ birth of stem cell sphe.pdf, Page: 5]. row 10 question: In the paper "bioprinting of high-performance hydrogel with in-situ birth of stem cell spheroids", what light wavelength and intensity parameters were utilized for the DLP bioprinting process? k24_c1200: The provided context does not specify the exact light wavelength and intensity parameters used for the DLP bioprinting process in the paper "3D bioprinting of high-performance hydrogel with in-situ birth of stem cell spheroids". If you have access to the full paper, you might find this information in the methods section or a similar part of the document. row 11 question: What is the primary technical limitation of 3D bioprinting thick tissue structures? k24_c1200: The primary technical limitation of 3D bioprinting thick tissue structures is the incorporation of a vascular network to provide sufficient nutrient support to the encapsulated cells within the printed structure. This is crucial for maintaining cell viability and function in thicker tissues [Source: Three-dimensional bioprinting for medical applications.pdf, Page: 3]. row 12 question: Which 3D bioprinting technique did the authors employ to fabricate vascularized scaffolds? k24_c1200: The authors employed extrusion-based bioprinting, inkjet bioprinting, and light-assisted bioprinting to directly fabricate vascularized scaffolds. These methods allow for the direct printing of cell-laden bioink in a continuous fashion, which is advantageous compared to other methods like sacrificial molding and cell sheet stacking [Source: Systematic review on the application of 3D-bioprinting technology in orthoregene.pdf, Page: 19]. row 13 question: Why is DLP-based 3D bioprinting considered to have an advantage over traditional extrusion-based bioprinting? k24_c1200: DLP-based 3D bioprinting is considered to have several advantages over traditional extrusion-based bioprinting: 1. **Higher Resolution and Speed**: DLP bioprinting offers higher resolution and faster printing speeds compared to extrusion-based methods. This is because DLP can crosslink entire layers at once using digital light projection, rather than adding material point by point or line by line, which significantly reduces processing time [Source: Review on Multicomponent Hydrogel Bioinks Based on Natural Biomaterials for Biop.pdf, Page: 4]. 2. **Reduced Mechanical Stress**: DLP bioprinting applies less mechanical shear stress on the cells compared to extrusion-based methods, which can exert significant pressure on cells, potentially leading to lower cell viability [Source: The microparticulate inks for bioprinting applications.pdf, Page: 13]. 3. **Improved Cell Viability**: The short printing time and nozzle-free technique of DLP bioprinting enhance cell viability, often achieving rates beyond 85–95% [Source: Precisely printable and biocompatible silk fibroin bioink for digital light proc.pdf, Page: 2]. 4. **Structural Integrity**: DLP technology can fabricate 3D structures with smoother surfaces and improved structural integrity, which enhances the mechanical properties of the printed constructs [Source: Development of 3D bioprinting From printing methods to biomedical applications.pdf, Page: 20]. 5. **Complex Geometries**: DLP is capable of producing complex 3D structures with high precision and intricate geometric details, which is beneficial for creating detailed tissue scaffolds and organ models [Source: Recent advances in 3D bioprinted polysaccharide hydrogels for biomedical applica.pdf, Page: 14]. Overall, these advantages make DLP-based 3D bioprinting a promising technology for applications requiring high precision and cell viability, such as tissue engineering and organ modeling. row 14 question: What is the primary role of the PDMS substrate in the DLP-based bioprinting process? k24_c1200: The provided context does not specifically mention the role of a PDMS (Polydimethylsiloxane) substrate in the DLP-based bioprinting process. Generally, in bioprinting, substrates like PDMS can be used for their biocompatibility and ability to support cell adhesion and growth. However, for a detailed explanation specific to DLP-based bioprinting, additional sources or context would be required. row 15 question: What is the main purpose of incorporating tetrapod-shaped ZnO (t-ZnO) microparticles into the 3D-printed scaffolds? k24_c1200: The main purpose of incorporating tetrapod-shaped ZnO (t-ZnO) microparticles into the 3D-printed scaffolds is to create interconnected channels and textured surfaces within the microstructured alginate (M-Alg) scaffolds. These features enhance the adhesion and maturation of primary mouse cortical neurons cultured on the scaffolds, promoting the formation of extensive 3D neural projections. This scaffold design shows potential for advanced neural tissue engineering applications [Source: 3D-printed microstructured alginate scaffolds for neural tissue engineering.pdf, Page: 1]. Additionally, the t-ZnO microparticles can be easily removed using a hydrophilic volatile acid like HCl, ensuring the absence of toxic residues post-fabrication, which is preferred over conventional particulate leaching methods [Source: 3D-printed microstructured alginate scaffolds for neural tissue engineering.pdf, Page: 4]. row 16 question: What biological characteristics did the primary mouse cortical neurons demonstrate when cultured on the M-Alg scaffolds? k24_c1200: When cultured on the M-Alg scaffolds, primary mouse cortical neurons demonstrated several biological characteristics: 1. **Enhanced Proliferation and Metabolic Activity**: Neurons exhibited significantly higher proliferation and metabolic activity on M-Alg scaffolds compared to P-Alg scaffolds. This was attributed to the increased surface area conducive to neuron growth and enhanced nutrition/oxygen transport facilitated by the channels embedded within the scaffold [Source: 3D-printed microstructured alginate scaffolds for neural tissue engineering.pdf, Page: 7]. 2. **Neuron Maturation and Network Formation**: The neurons developed morphological, electrophysiological, and molecular features as they matured. By Day 8, significant neuron outgrowth was observed, and by Day 15, a more complex assembly of neuronal networks emerged, accompanied by widespread distribution of dendritic spines, suggesting increased plasticity in these networks [Source: 3D-printed microstructured alginate scaffolds for neural tissue engineering.pdf, Page: 7]. 3. **Spontaneous Neuronal Activity**: Spontaneous neuronal activity was detected in the established neuronal network formed in the M-Alg scaffolds by Day 8, indicating functional intercellular connections [Source: 3D-printed microstructured alginate scaffolds for neural tissue engineering.pdf, Page: 7]. 4. **Robust Adhesion and Growth**: Neurons exhibited robust adhesion and growth on M-Alg scaffolds, with maturation of neuronal networks evidenced by extensive neurite outgrowth and spontaneous neural activity [Source: 3D-printed microstructured alginate scaffolds for neural tissue engineering.pdf, Page: 10]. 5. **Complex Neuronal Network Development**: The presence of synapses, as evidenced by synaptophysin staining, indicated synaptic vesicle formation along the neurites exclusively in the M-Alg scaffolds, supporting complex neuronal network development and synaptic connectivity [Source: 3D-printed microstructured alginate scaffolds for neural tissue engineering.pdf, Page: 9]. row 17 question: What is the purpose of bioink with GelMA + PEDOT? k24_c1200: The purpose of a bioink composed of GelMA (gelatin methacryloyl) and PEDOT (poly(3,4-ethylenedioxythiophene)) is to create a biocompatible and electroconductive material that can be used in 3D bioprinting applications. This combination leverages the excellent biocompatibility and tunable mechanical properties of GelMA with the electroconductive properties of PEDOT. Such bioinks are particularly useful for applications that require electrical stimulation, such as in the development of biomimetic muscle structures or enhanced functional properties of regenerated muscle tissues [Source: In situ magnetic-field-assisted bioprinting process using magnetorheological bio.pdf, Page: 5]. Additionally, the incorporation of PEDOT into a hydrogel solution based on gelatin and fibrinogen has been used to create constructs with enhanced response to electrical stimulation, which could be beneficial for manufacturing improved bioactuators and biocapacitors [Source: Merging BioActuation and BioCapacitive properties A 3D bioprinted devices to sel.pdf, Page: 8]. row 18 question: How is kidney function related to the progression of kidney fibrosis? k24_c1200: Kidney function inversely correlates with interstitial kidney fibrosis. As kidney fibrosis progresses, it negatively impacts kidney function. This relationship highlights the importance of developing novel targeted anti-fibrotic therapies, which could potentially stabilize kidney function and slow down the progression of chronic kidney disease (CKD) [Source: A bioprinted and scalable model of human tubulo-interstitial kidney fibrosis.pdf, Page: 10]. row 19 question: What specific growth factors are delivered by the PODS (Polyhedrin Delivery System) in this study to accelerate vascular graft development? k24_c1200: In this study, the PODS (Polyhedrin Delivery System) delivers two specific growth factors to accelerate vascular graft development: VEGF-165 and TGF-β1. VEGF-165 is used for the differentiation of adipose-derived stem cells (ADSCs) into endothelial cells (dECs), while TGF-β1 is used for the differentiation into smooth muscle cells (dSMCs) [Source: Accelerating vascular graft development Adipose-derived stem cells and PODS Poly.pdf, Page: 2]. row 20 question: Which bioprinting technique did the researchers employ to fabricate the vascular grafts? k24_c1200: The researchers employed extrusion-based bioprinting to fabricate vascular grafts. This technique involves the extrusion of bioinks through a nozzle to create structures layer by layer, which is suitable for creating vascular scaffolds and small-diameter vascular constructs [Source: Bioprinted vascular tissue Assessing functions from cellular tissue to organ lev.pdf, Page: 8]. row 21 question: In additive-free hyaluronic acid-based bioink for 3D bioprinting of bone marrow microenvironments, what are the two functional groups introduced onto the hyaluronic acid (HA) backbone during the one-pot synthesis? k24_c1200: The two functional groups introduced onto the hyaluronic acid (HA) backbone during the one-pot synthesis are alkyl side chains and methacrylamide groups. The alkyl side chains enhance physical crosslinking via hydrophobic interactions, while the methacrylamide groups allow for covalent photo-crosslinking [Source: Additive-free hyaluronic acid-based bioink for 3D bioprinting of bone marrow mic.pdf, Page: 1]. row 22 question: What are the two distinct bioprinting approaches allowed by the HA-based bioink? k24_c1200: The HA-based bioink allows for two distinct bioprinting approaches: 1. Bioprinting of encapsulated cells: This involves printing cells that are encapsulated within the bioink, allowing for precise placement and organization within the printed structure. 2. Injection of cells into pre-printed structures: This approach allows for the precise placement of hematopoietic and stromal cells into an already printed construct, enabling the creation of complex tissue models [Source: Additive-free hyaluronic acid-based bioink for 3D bioprinting of bone marrow mic.pdf, Page: 1]. row 23 question: What are the three core bioprinting techniques used to construct in vitro tumor organoid models? k24_c1200: The three core bioprinting techniques used to construct in vitro tumor organoid models are extrusion-based bioprinting, inkjet-based bioprinting, and light-curing bioprinting [Source: Advanced tumor organoid bioprinting strategy for oncology research.pdf, Page: 2]. row 24 question: What four characteristics should a bioink possess to successfully construct tumor organoid models? k24_c1200: To successfully construct tumor organoid models, a bioink should possess the following four characteristics: 1. **Printability**: The bioink must have the appropriate rheological properties to ensure smooth flow during printing and maintain its shape after deposition [Source: Unleashing the Power of Undifferentiated Induced Pluripotent Stem Cell Bioprinti.pdf, Page: 5]. 2. **Biocompatibility**: The bioink should ensure the viability and functionality of encapsulated cells without inducing toxicity or inflammation [Source: Unleashing the Power of Undifferentiated Induced Pluripotent Stem Cell Bioprinti.pdf, Page: 5]. 3. **Favorable Mechanical Properties**: The bioink must provide the mechanical properties necessary for cell adhesion, proliferation, and differentiation [Source: 3D bioprinted breast tumor-stroma models for pre-clinical drug testing.pdf, Page: 2]. 4. **Biological Stability**: The bioink should maintain its structural integrity and support the biological functions of the cells over time [Source: Advanced tumor organoid bioprinting strategy for oncology research.pdf, Page: 2]. row 25 question: What are the three main core techniques used in bioprinting to construct in vitro tumor organoid models? k24_c1200: The three main core techniques used in bioprinting to construct in vitro tumor organoid models are extrusion-based bioprinting, inkjet-based bioprinting, and light-curing bioprinting [Source: Advanced tumor organoid bioprinting strategy for oncology research.pdf, Page: 2]. row 26 question: What are the four key characteristics that bioinks must possess to successfully construct tumor organoid models? k24_c1200: The four key characteristics that bioinks must possess to successfully construct tumor organoid models are printability, biocompatibility, favorable mechanical properties, and biological stability [Source: Advanced tumor organoid bioprinting strategy for oncology research.pdf, Page: 2]. row 27 question: What are the primary factors hindering the clinical translation of 3D bioprinted products (BPPs) from bench to bedside? k24_c1200: The primary factors hindering the clinical translation of 3D bioprinted products (BPPs) from bench to bedside include: 1. **Personalization of Design**: BPPs need to be patient-specific due to the immunity-, tissue-, structure-, and function-specific nature of the repaired parts. This requires the design of BPPs to replicate the complexity and specificity of natural tissues across multi-materials and multi-scale structures, which introduces extensive design parameters and significant trial and error [Source: AI-driven 3D bioprinting for regenerative medicine From bench to bedside.pdf, Page: 1]. 2. **Scaling Up of Production**: There are challenges in scaling up production while ensuring strict quality control to meet international regulatory frameworks. Current BPPs are typically designed and produced in small batches, making it difficult to amortize R&D costs and maintain reproducibility and contamination-free manufacturing [Source: AI-driven 3D bioprinting for regenerative medicine From bench to bedside.pdf, Page: 1]. 3. **Regulatory Approval Pathways**: The regulatory approval pathway for 3D bioprinted products is not yet fully clear or harmonized globally. This requires collaborative efforts to establish clear evaluation criteria and approval processes [Source: 3D bioprinting patient-specific grafts for tendonligament repair in motion emerg.pdf, Page: 7]. 4. **Standardization and Reproducibility**: There is a lack of standardized bioinks and bioprinting processes, leading to variability in composition, consistency, properties, and functionality, which complicates cross-study comparisons and limits result reproducibility [Source: Natural macromolecule-based bioinks for 3D bioprinting A systematic review of co.pdf, Page: 14]. 5. **Cost and Scalability**: Bespoke bioprinted constructs are currently expensive to fabricate. Improvements in printing speed and economies of scale are needed to reduce costs and make bioprinting more industrialized [Source: Bioprinting for craniofacial reconstruction A review of advancements clinical us.pdf, Page: 12]. 6. **Technical Limitations**: Challenges such as print resolution, printing speed, and maintaining cell viability during prolonged print times are significant technical hurdles [Source: Bioprinting for craniofacial reconstruction A review of advancements clinical us.pdf, Page: 10]. 7. **Long-term In Vivo Studies**: There is a lack of long-term in vivo studies to confirm the safety and efficacy of bioprinted products, which is crucial for clinical acceptance [Source: 3D bioprinting patient-specific grafts for tendonligament repair in motion emerg.pdf, Page: 7]. Addressing these challenges requires coordinated efforts across multiple disciplines, including bioengineering, clinical practice, and regulatory oversight. row 28 question: Define the term "bioprinting". k24_c1200: Bioprinting is defined as "the use of computer-aided transfer processes for patterning and assembly of living and non-living materials with a prescribed 2D or 3D organization to produce bio-engineered structures" [Source: Bioprinting for the Biologist.pdf, Page: 1]. It involves the additive manufacturing of materials containing living cells to create complex, three-dimensional biological constructs [Source: Cell viability in extrusion bioprinting the impact of process parameters bioink .pdf, Page: 1]. row 29 question: What are the primary components of the bioink developed to mimic the melanoma microenvironment? k24_c1200: The bioink developed to mimic the melanoma microenvironment is primarily composed of alginate and microfibrillated cellulose. These materials were chosen because they complement each other's features to create a printable, crosslinkable material that does not require any chemical adaptations or more complex processing [Source: An alginate-cellulose based bioink mimics the viscoelastic features of the melan.pdf, Page: 2]. row 30 question: What biological behaviors of melanoma cells were investigated in relation to the viscoelastic features of the bioink? k24_c1200: The study investigated the survival, proliferation, and migratory behavior of melanoma cells in relation to the viscoelastic features of the bioink. Specifically, it evaluated the survival and proliferation of cells and printed tumor spheroids, as well as determined different migratory behaviors by comparing alginate to AlgCell bioink [Source: An alginate-cellulose based bioink mimics the viscoelastic features of the melan.pdf, Page: 1]. Additionally, the study explored the potential of the bioink as a model for tumor invasion and metastasis [Source: An alginate-cellulose based bioink mimics the viscoelastic features of the melan.pdf, Page: 2].